The purpose of this study was to evaluate chorionicity and zygosity as risk factors for adverse perinatal outcomes in twins. STUDY DESIGN: A population-based, retrospective cohort study was conducted of all twin deliveries in Nova Scotia, Canada, from 1988 to 1997. Chorionicity was established by histologic examination. Zygosity was determined by chorionicity, sex, and infant blood group. Three groups were established: monochorionic/monozygotic twins, dichorionic/dizygotic twins, and dichorionic/majority monozygotic twins. RESULTS: Outcomes from 1008 twin pregnancies were analyzed. Monochorionic/monozygotic twins had lower mean birth weights compared with dichorionic/dizygotic twins. Rates of perinatal mortality of at least 1 twin were significantly higher among monochorionic/monozygotic twins relative to dichorionic/dizygotic twins (relative risk, 2.5; 95% CI, 1.1-2.5). Dichorionic/majority monozygotic twins had similar perinatal outcomes compared with dichorionic/dizygotic twins. CONCLUSION: Monochorionicity increases the risk of adverse perinatal outcome, whereas the effect of zygosity is less clear. Because chorionicity can be determined by prenatal ultrasound scanning, this information should be considered in the prenatal care of twin pregnancies. (Am J Obstet Gynecol 2002;186:579-83.) 
Twin gestation, which represents 1% to 2% of all pregnancies, results from 1 of 2 mechanisms that determine zygosity. Dizygotic (not identical) twins originate from the fertilization of 2 oocytes, thereby giving rise to diamniotic, dichorionic placentation. Monozygotic (identical) twins originate from fertilization of 1 egg, which undergoes subsequent mitotic duplication. Depending on the timing of this division, monozygotic twins may have monochorionic or dichorionic placentation. Zygosity can be predicted by ultrasonographic examination in approximately 55% to 65% of twin pregnancies, with the use of well-established chorionicity markers and fetal sex. 1, 2 Definitive zygosity testing is possible in utero but requires invasive procedures (such as amniocentesis) and is rarely indicated. 3 Chorionicity, on the other hand, can be accurately determined by prenatal ultrasound scanning. 4 Monochorionic placentation increases the risk of early pregnancy loss (before 24 weeks) 5 and may result in serious pregnancy complications (such as twin-to-twin transfusion syndrome). Monochorionicity and monozygosity have been associated with increased risks of preterm birth among twins. [5] [6] [7] Monozygotic twins have been reported to have an increased risk of congenital anomalies, growth restriction, and perinatal death. 6, 8, 9 It is not clear, however, whether these complications are related to monochorionicity or monozygosity.
Many of the previous reports on the relationship between chorionicity and zygosity and perinatal outcomes in twin pregnancies have focused on one factor or the other. The objective of this study was to simultaneously evaluate chorionicity and zygosity to determine whether chorionicity or zygosity or both are important risk factors for adverse perinatal outcome in twins.
Material and methods
A population-based retrospective cohort study of all twin gestations in Nova Scotia from 1988 to 1997 was conducted with the use of the Nova Scotia Atlee Perinatal Database. The provincial perinatal database includes information on all births of ≥500 g that occur in Nova Scotia and most of the out-of-province deliveries among Nova Scotia residents. Information pertaining to the prenatal period, labor and delivery events, and neonatal outcomes are abstracted from hospital medical records by health records personnel. Reabstraction studies and validation studies have been conducted as part of an ongoing database quality assurance program and show that the data are reliable. 10 Pregnancies with one or both infants weighing <500 g, monoamniotic twins, and conjoined twins were excluded. Pregnancies with 1 or 2 intrauterine fetal deaths were excluded from all analyses, except for the analysis of perinatal deaths.
Chorionicity was established by histologic examination, and zygosity was determined by chorionicity, sex, and infant blood group. The cohort was divided into 3 clinically identifiable groups: monochorionic twins (and therefore monozygotic [MC/MZ]), dichorionic twins with different sex or different blood group at birth (and therefore dizygotic [DC/DZ]), and dichorionic twins of the same sex and same blood group at birth. Assuming population probabilities of 30% and 70% for monozygotic and dizygotic twins, respectively, approximately two thirds of same sex, same blood group dichorionic twin pairs are monozygotic. 11 Therefore, this group of dichorionic twins was classified as dichorionic/majority monozygotic (DC/MMZ). Gestational age was calculated with the last menstrual period. If the last menstrual period was unknown or if there was more than a 2-week discrepancy between the gestational age estimate by last menstrual period and the clinical examination, the clinical estimate was used.
The outcomes that were considered in this study included spontaneous or medically indicated preterm birth, birth weight discordance, intrauterine growth restriction (IUGR), and perinatal death. Preterm birth was defined as a delivery that occurred before 37 completed weeks of gestation; early preterm birth was defined as delivery that occurred before 32 weeks. Preterm births were subdivided into births that resulted from spontaneous onset of labor (including premature rupture of the membranes) and medically indicated preterm births (induction of labor for maternal or fetal indications or elective cesarean delivery without labor). IUGR was defined as birth weight of <3rd percentile for gestational age, with Canadian twin and sex-specific birth weight curves. 12 Perinatal death was defined as the death of a fetus ≥500 g or death of a live-born infant before 28 days of age.
Statistical analyses were performed with SAS software (version 6.12; SAS Institute, Cary, NC). To compare proportions, χ 2 tests were used. Because preterm delivery is prevalent among twin pregnancies, odds ratios do not provide good estimate of relative risks. Therefore, Poisson regression was used to determine adjusted rate ratios and 95% CI, while controlling for confounders. Potential confounders included smoking status of the mother, maternal age, nulliparity, and major fetal anomalies. An additional confounder considered for the analyses of perinatal mortality was IUGR. For the purpose of controlling for the confounding effects of IUGR on perinatal death, the definition of IUGR included babies below the bottom 10th percentile, using twin sex-specific birth weight curves. 12 Regression modeling was performed, using a step-wise approach, excluding the variable with the highest probability value and evaluating the effect on the model. Variables were maintained in the model if the probability values from the likelihood ratio test were <.05. For each outcome that was evaluated, the same confounders were included so that results could be compared among the same subsets of women. Rate ratios for each outcome were calculated for MC/MZ twins and for DC/MMZ twins relative to DC/DZ twins.
Results
The total cohort included 1080 twin pregnancies. Fiftytwo dichorionic twin pairs were excluded because of missing blood group information. Twenty pregnancies with at least 1 intrauterine fetal death (14 monochorionic and 6 dichorionic) were excluded from all but the perinatal death analyses. Of the remaining 1008 pregnancies, 280 births (27.7%) were MC/MZ; 414 births (41.1%) were DC/DZ, and 314 births (31.2%) were DC/MMZ.
As shown in Table I , there were no significant differences in maternal age, smoking status of the mother, antepartum bleeding, type of labor (spontaneous, induced, or no labor), pregnancy-induced hypertension, chronic hypertension, abruptio placentae, premature rupture of membranes, or major anomalies for MC/MZ twins or DC/MMZ twins compared with DC/DZ twins. As expected, oligohydramnios and polyhydramnios occurred more frequently in the MC/MZ twins group compared with DC/DZ twins. Nulliparity was more frequent in MZ/MC pregnancies and in DC/MMZ pregnancies compared with DC/DZ twins.
The incidence of preterm birth (<37 weeks of gestation) was 44.4% for DC/DZ twins, 46.5% for DC/MMZ twins, and 46.8% for MC/MZ twins. Table II shows the adjusted rate ratios for preterm birth by zygosity/chorionicity group. There was no evidence of significantly increased rates of either spontaneous or medically indicated preterm delivery before 37 weeks for DC/MMZ twins or MC/MZ twins, relative to DC/DZ twins. Among preterm deliveries of <32 weeks of gestation, DC/MMZ twins had increased rates (not significant) for both spontaneous and medically indicated deliveries compared with the DC/DZ twins. Among the MC/MZ twins, only the rates of medically indicated preterm deliveries of <32 weeks were increased (not significant) compared with DC/DZ twins. Table III shows mean birth weights of twins by chorionicity/zygosity group. The mean birth weights of the bigger and smaller twins in the MC/MZ twins were significantly less than the mean birth weights of the bigger and smaller DC/DZ twins. The mean birth weights of the DC/MMZ twins did not differ significantly from the DC/DZ twins. The proportion of twin pairs with >25% weight discordancy did not differ significantly between MC/MZ twins or DC/MMZ twins compared with DC/DZ twins, although MC/MZ twins had the highest proportion (8.6%) of twin pairs with >25% weight discrepancy. MC/MZ twins had increased rates of IUGR below the third percentile compared with DC/DZ twins, although the rate ratios did not achieve statistical significance after adjustment for age, major anomalies, and maternal smoking. The IUGR rate among DC/MMZ twins was not significantly different from DC/DZ twins (Table IV) .
Perinatal death of at least 1 twin was more likely in MC/MZ twins compared with DC/DZ twins, with an adjusted rate ratio of 2.45 (95% CI, 1.10-5.47; Table V ). The rate ratios for perinatal mortality of both twins was increased in both DC/MMZ twins and MC/MZ twins relative to DC/DZ twins, but only significantly so for MC/MZ twins.
Comment
Chorionicity was determined by histologic examination for all twins in this cohort, although zygosity was inferred with chorionicity, sex, and blood group. Given the probability of dichorionic twins being the same sex and same blood group, we estimated that approximately 64% of twins in this category would be monozygotic. 11 Therefore, some of the twins in the DC/MMZ group were incorrectly classified as monozygotic. If monozygotic twins are at increased risk for the outcomes that were studied, then the rate ratios we reported for the DC/MMZ group were conservative. The distribution by chorionicity observed in this study is comparable with other reports. 1, 5, 13 However, the proportion of monozygotic twins in this cohort is higher than reports from studies of proven zygosity. 7 This study attempted to simultaneously evaluate chorionicity and zygosity as possible risk factors for preterm birth in twin pregnancies. In contrast to other reports, neither zygosity nor chorionicity appeared to influence the risk of spontaneous or medically indicated preterm birth. [5] [6] [7] However, there was a suggestion of increased rates of medically indicated preterm deliveries among MC/MZ twins. This finding is not unexpected because MC/MZ twins had higher rates of IUGR and congenital anomalies compared with DC/DZ twins (although not statistically significant). Although increased rates of congenital anomalies and IUGR among MC/MZ twins may increase the risk of preterm birth, based on our findings, the high rates of prematurity among twins appear to be independent of chorionicity and zygosity.
The increased risk of perinatal deaths among MC/MZ twins persisted even after adjustment for major fetal anomalies and IUGR. This observation suggests that the higher rates of perinatal mortality among MC/MZ twins may be related to other known complications of monochorionicity (such as twin-to-twin transfusion syndrome, which was not specifically accounted for in our analysis). Our findings are consistent with the literature. 7, [14] [15] [16] Derom et al 16 reported higher rates of perinatal mortality among monozygotic twins than dizygotic twins, although the difference is believed to be mainly a result of the chorionicity difference between the groups. Machin et al 7 also reported a higher perinatal mortality rate in MC/MZ twins compared with DC/MZ twins. Because the perinatal mortality rate among DC/MMZ twins was similar to DC/DZ twins, the increased perinatal mortality rate among MC/MZ twins appears to be related to chorionicity and not zygosity. Whether this finding would hold with a pure DC/MZ group remains to be determined.
The distribution of birth weights by percentile for dichorionic twins (regardless of zygosity) in our cohort follows the distribution of the Canadian population of twins, although the monochorionic twins were statistically smaller than the reported curves (only the 3rd percentiles are reported, but the findings were similar for 5th and 10th percentiles). The trend toward an increased rate of IUGR and lower birth weights in monochorionic/monozygotic twins, compared with dichorionic/ dizygotic twins, agrees with the previous reports. 7 Intertwin growth disparity was similar among dichorionic and monochorionic twins in our study, which confirm the findings of Sebire et al. 13 Other investigators have demonstrated greater inter-twin disparities among dizygotic versus monozygotic twins, dizygotic twins with fused placentas versus separate placentas, and monochorionic twins with proven vascular anastomoses versus dichorionic twins. 9, 13, 17 These heterogenous findings suggest that mean birth weight and inter-twin growth disparity among twins is determined by many factors that are not likely limited to chorionicity and zygosity. In this large population-based study of twin births, we confirmed previous reports of adverse perinatal outcomes that were related to monochorionic twins. Monochorionicity was a risk factor for decreased birth weight and perinatal death, whereas monozygosity did not appear to be associated with adverse outcomes. However, the inability to definitively determine zygosity on all twins limits the conclusions regarding monozygosity. Definitive zygosity testing on a population basis is not practical, so alternative approaches to determine zygosity (such as the approach used in this study) will be necessary. Because chorionicity is a risk factor for several adverse perinatal outcomes and can be determined by prenatal ultrasonographic scanning, these findings support the incorporation of this clinically relevant information into prenatal care strategies for twin pregnancies.
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